Femme et Homme
- | Pays :
- Sweden
- Italy
- France
- Les 4 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to evaluate the efficacy of a 100 mg dose of saredutant compared to placebo in patients with generalized anxiety disorder. The secondary objectives are to evaluate the efficacy of saredutant on disability and quality of life in patients with generalized anxiety disorder, and to evaluate blood levels of saredutant.
Critère d'inclusion
- Generalized anxiety